U1 snRNA as an effective vector for stable expression of antisense molecules and for the inhibition of the splicing reaction.

[1]  I. Bozzoni,et al.  Exon skipping and duchenne muscular dystrophy therapy: selection of the most active U1 snRNA antisense able to induce dystrophin exon 51 skipping. , 2010, Molecular therapy : the journal of the American Society of Gene Therapy.

[2]  L. Tora,et al.  Human U1 snRNA forms a new chromatin-associated snRNP with TAF15 , 2009, EMBO reports.

[3]  A. Masuda,et al.  Tannic acid facilitates expression of the polypyrimidine tract binding protein and alleviates deleterious inclusion of CHRNA1 exon P3A due to an hnRNP H-disrupting mutation in congenital myasthenic syndrome , 2009, Human molecular genetics.

[4]  A. Musarò,et al.  Long-term benefit of adeno-associated virus/antisense-mediated exon skipping in dystrophic mice. , 2008, Human gene therapy.

[5]  A. Musarò,et al.  Chimeric adeno-associated virus/antisense U1 small nuclear RNA effectively rescues dystrophin synthesis and muscle function by local treatment of mdx mice. , 2006, Human gene therapy.

[6]  A. Musarò,et al.  Body-wide gene therapy of Duchenne muscular dystrophy in the mdx mouse model. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[7]  I. Bozzoni,et al.  Chimeric snRNA molecules carrying antisense sequences against the splice junctions of exon 51 of the dystrophin pre-mRNA induce exon skipping and restoration of a dystrophin synthesis in Δ48-50 DMD cells , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[8]  I. Bozzoni,et al.  The Rev protein is able to transport to the cytoplasm small nucleolar RNAs containing a Rev binding element. , 1999, RNA.

[9]  C. Guthrie,et al.  An RNA switch at the 5' splice site requires ATP and the DEAD box protein Prp28p. , 1999, Molecular cell.

[10]  Manoel Luis Costa,et al.  MyoD converts primary dermal fibroblasts, chondroblasts, smooth muscle, and retinal pigmented epithelial cells into striated mononucleated myoblasts and multinucleated myotubes. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[11]  A. Weiner,et al.  Formation of the 3′ end of U1 snRNA requires compatible snRNA promoter elements , 1986, Cell.

[12]  Stephen M. Mount,et al.  The U1 small nuclear RNA-protein complex selectively binds a 5′ splice site in vitro , 1983, Cell.